Encarnación Blanco-Reina

Dr. Encarnación Blanco-Reina

Pharmacology and Therapeutics Department, School of Medicine, University of Málaga, Málaga, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2014 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
EBEncarnación Blanco-Reina
Encarnación Blanco-Reina
GAGabriel Ariza‐Zafra
Gabriel Ariza‐Zafra
RORicardo Ocaña-Riola
Ricardo Ocaña-Riola
MLMatilde León‐Ortiz
Matilde León‐Ortiz

9 November 2014 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
EBEncarnación Blanco-Reina
Encarnación Blanco-Reina
GAGabriel Ariza-Zafra
Gabriel Ariza-Zafra
RORicardo Ocaña-Riola
Ricardo Ocaña-Riola
MLMatilde León-Ortíz
Matilde León-Ortíz
IBInmaculada Bellido-Estévez
Inmaculada Bellido-Estévez

1 December 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EBEncarnación Blanco-Reina
Encarnación Blanco-Reina
MGMaria Rosa García-Merino
Maria Rosa García-Merino
RORicardo Ocaña-Riola
Ricardo Ocaña-Riola
LALorena Aguilar-Cano
Lorena Aguilar-Cano
JVJennifer Valdellós
Jennifer Valdellós
GAGabriel Ariza-Zafra
Gabriel Ariza-Zafra
Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was published recently. In this study the objectives were to determine the prevalence of potentially inappropriate medication prescribing (PIM) in primary care using STOPP versions 1 (v1) and 2 (v2), as well as 2012 AGS Beers criteria, and analyze the factors associated with inappropriate prescribing according to STOPP/START v2. A cross-sectional study was carried out including community-dwelling older adults over the age of 65. Sociodemographic, clinical, functional and comprehensive drug therapy data were collected. The primary endpoint was the percentage of patients receiving at least one PIM. This variable was measured using three tools: STOPP v1, 2012 AGS Beers criteria and STOPP v2. Similarly, the percentage of patients receiving at least one potential prescribing omission (PPO) was calculated using START versions 1 and 2. A total of 1,615 prescriptions were reviewed. The median number of medications per patient was 7.1 drugs (±3.8). The prevalence of elderly people exposed to polypharmacy (≥5 medications) was 72.9%, whereas 28.4% of the participants took ≥10 drugs regularly. PIM were present in 18.7%, 37.3% and 40.4% of participants, according to the STOPP v1, 2012 Beers criteria and STOPP v2, respectively. According to STOPP v2, the number of medications taken (OR: 1.14, 1.06–1.25), the presence of a psychological disorder (OR: 2.22, 1.13–4.37) and insomnia (OR: 3.35, 1.80–6.32) were risk factors for taking a PIM. The prevalence of PPOs was 34.7% and 21.8% according to version 1 and 2, respectively. In conclusion, STOPP-START criteria have been remarkably modified, which is evidenced by the different prevalence rates detected using version 2, as compared to version 1. In fact, the level of agreement between version 1 and the updated version is only moderate. Special attention should be paid on benzodiazepines, which keep being the most frequent PIM.

24 July 2019 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
EBEncarnación Blanco-Reina
Encarnación Blanco-Reina
JVJenifer Valdellós
Jenifer Valdellós
LALorena Aguilar-Cano
Lorena Aguilar-Cano
MGMaria Rosa García-Merino
Maria Rosa García-Merino
RORicardo Ocaña-Riola
Ricardo Ocaña-Riola
IBInmaculada Bellido-Estévez
Inmaculada Bellido-Estévez

1 May 2000 in European Journal of Pharmacology
Verified
Journal Article
Closed access
JCJose pedro de la cruz
Jose pedro de la cruz
EBEncarnación Blanco-Reina
Encarnación Blanco-Reina
FCFelipe Sánchez de la Cuesta
Felipe Sánchez de la Cuesta

4 March 2024 in Pharmacological Research
Verified
Journal Article
Open access
JBJosep Eladi Baños
Josep Eladi Baños
EBEncarnación Blanco-Reina
Encarnación Blanco-Reina
IBI. Bellido-Estévez
I. Bellido-Estévez
FBF. Bosch
F. Bosch
MCM.R. Cabello
M.R. Cabello
ESE. Sanz
E. Sanz
Pharmacology has broadened its scope considerably in recent decades. Initially, it was of interest to chemists, doctors and pharmacists. In recent years, however, it has been incorporated into the teaching of biologists, molecular biologists, biotechnologists, chemical engineers and many health professionals, among others. Traditional teaching methods, such as lectures or laboratory work, have been superseded by the use of new pedagogical approaches to enable a better conceptualization and understanding of the discipline. In this article, we present several new methods that have been used in Spanish universities. Firstly, we describe a teaching network that has allowed the sharing of pedagogical innovations in Spanish universities. A European experience to improve prescribing safety is described in detail. The use of popular films and medical TV series in biomedical students shows how these audiovisual resources can be helpful in teaching pharmacology. The use of virtual worlds is detailed to introduce this new approach to teaching. The increasingly important area of the social aspects of pharmacology is also considered in two sections, one devoted to social pharmacology and the other to the use of learning based on social services to improve understanding of this important area. Finally, the use of Objective Structured Clinical Evaluation in pharmacology allows to know how this approach can help to better evaluate clinical pharmacology students. In conclusion, this article allows to know new pedagogical methods resources used in some Spanish universities that may help to improve the teaching of pharmacology.